# Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

> **NCT06083012** · — · ACTIVE_NOT_RECRUITING · sponsor: **Volta Medical** · enrollment: 186 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Arrhythmia
- Arrhythmias, Cardiac

## Interventions

- **DEVICE:** Cardiac mapping

## Key facts

- **NCT ID:** NCT06083012
- **Lead sponsor:** Volta Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-27
- **Primary completion:** 2027-04-27
- **Final completion:** 2027-04-27
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06083012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06083012, "Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06083012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*